February 07, 2019
As part of our commitment to the development of quality clinical practice guidelines, ASCP is collaborating with the College of American Pathologists (CAP) in the development of an evidence-based monoclonal gammopathies guideline. CAP assembled an expert panel that is developing an evidence-based clinical practice guideline that aims to reduce variability, identify optimal testing and improve the accurate diagnosis of patients with monoclonal gammopathies (MGs).
This guideline will focus on the initial diagnosis and standardization of testing serum and urine specimens. The process for the detection of MGs is highly complex. To obtain an accurate diagnosis, diagnostic data must be compiled from several areas of the laboratory. This complex cascade of laboratory testing can vary widely across medical teams, and such variability could spur inconsistent or poor outcomes.
A draft summary of 13 recommendations for the guideline, “Laboratory Work-up and Initial Diagnosis of Monoclonal Gammopathies,” is now open online for public review and comment through February 22, 2019.
In addition to ASCP, medical societies collaborating with the CAP on the guideline include the American Association for Clinical Chemistry (AACC), the American Society of Hematology (ASH) and the International Myeloma Working Group (IMWG).
ASCP encourages all relevant stakeholders—including pathologists, hematologists, oncologists, hospital or laboratory administrators, and patient advocacy group representatives—to read and comment on the draft guidelines by February 22, 2019. Learn more and comment on the draft guideline here.
Other articles in ePolicy News February 2019
ASCP Urges CMS to Reconsider NGS NCD
Did You Catch the (Free) PAMA Webinar?
ASCP to Conduct 2019 Wage Survey
To read more articles from ePolicy News click here.
For more information regarding ASCP's advocacy initiatives and policy positions, please contact ASCP's Center for Public Policy at (202) 408-1110.
ASCP ePolicy News is supported by an unrestricted grant from Hologic.
ADVERTISEMENT